13-Methyltetradecanoic acid
| Names | |
|---|---|
| Preferred IUPAC name
13-Methyltetradecanoic acid | |
| Other names
13-Methylmyristic acid | |
| Identifiers | |
3D model (JSmol) |
|
| ChEBI | |
| ChEMBL | |
| ChemSpider | |
| ECHA InfoCard | 100.164.501 |
| EC Number |
|
PubChem CID |
|
| UNII | |
CompTox Dashboard (EPA) |
|
| |
| |
| Properties | |
| C15H30O2 | |
| Molar mass | 242.403 g·mol−1 |
| Hazards | |
| GHS labelling: | |
![]() | |
| Warning | |
| H315, H319, H335, H413 | |
| P261, P264, P271, P273, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, P501 | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references | |
13-Methyltetradecanoic acid, also known as isopentadecanoic acid (or iso-C15:0), is a 15-carbon branched-chain saturated fatty acid with the chemical formula C15H30O2 and a molecular weight of 242.4 g/mol. Isopentadecanoic acid is classified as a long-chain fatty acid, a branched-chain saturated fatty acid, and a methyl-branched fatty acid.[1]
Isopentadecanoic acid has been shown to induce apoptotic cell death and inhibition of tumor growth in human bladder cancer cells.[2] For these reasons, it has been considered a potential chemotherapeutic supplement.
References
- ↑ PubChem. "13-Methyltetradecanoic Acid". pubchem.ncbi.nlm.nih.gov. Retrieved 2026-08-15.
- ↑ Tianxin Lin; XinBao Yin; Qingqing Cai; Xinlan Fan; Kewei Xu; Li Huang; Junhua Luo; Jianping Zheng; Jian Huang (2010). "13-Methyltetradecanoic acid induces mitochondrial-mediated apoptosis in human bladder cancer cells". Urologic Oncology: Seminars and Original Investigations. 30 (3): 339–345. doi:10.1016/j.urolonc.2010.04.011. PMID 20843711.
Categories:

